PembrolizumabInterstitial lung disease: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1778卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71173-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：370 / 370

相关论文

共 50 条

[1] PembrolizumabInterstitial lung disease: case report
Reactions Weekly, 2020, 1817 (1) : 270 - 270
[2] Amiodarone/pembrolizumabInterstitial lung disease: case report
Reactions Weekly, 2023, 1945 (1) : 40 - 40
[3] PembrolizumabInterstitial lung disease with alveolar haemorrhage: case report
Reactions Weekly, 2019, 1734 (1) : 405 - 405
[4] PembrolizumabInterstitial lung disease, pneumonia and respiratory failure: case report
Reactions Weekly, 2020, 1832 (1) : 246 - 246
[5] PembrolizumabInterstitial lung disease in the form of pneumonitis NOS: case report
Reactions Weekly, 2020, 1826 (1) : 274 - 274
[6] Nivolumab/pembrolizumabInterstitial lung disease: 2 case reports
Reactions Weekly, 2023, 1983 (1) : 366 - 366
[7] Nivolumab/pembrolizumabInterstitial lung disease: 14 case reports
Reactions Weekly, 2019, 1776 (1) : 333 - 333
[8] PembrolizumabInterstitial-lung-disease, congestive heart failure and impaired cardiac ejection: case report
Reactions Weekly, 2022, 1907 (1) : 406 - 406
[9] Atezolizumab/nivolumab/pembrolizumabInterstitial lung disease: 5 case reports
Reactions Weekly, 2022, 1929 (1) : 115 - 115
[10] PembrolizumabInterstitial pneumonia: case report
Reactions Weekly, 2022, 1919 (1) : 494 - 494

← 1 2 3 4 5 →